文献速递急性肾损伤

肾小管分泌可区分肝硬化急性肾损伤的病因

Kidney Tubule Secretion Can Discriminate the Cause of Acute Kidney Injury in Cirrhosis.
PubMed 文献 · Clin J Am Soc Nephrol · 2025-09-16

在北美四家三级医疗中心纳入76例肝硬化合并急性肾损伤的住院患者,检测内源性分泌标志物的尿浆比值并计算综合分泌评分。急性肾小管坏死患者的分泌评分中位数显著低于肾前性氮质血症和肝肾综合征,综合分泌评分对急性肾小管坏死的诊断具有良好区分能力。

要点

  • 肝硬化合并急性肾损伤患者中,急性肾小管坏死的综合分泌评分中位数显著低于肾前性氮质血症和肝肾综合征。
  • 综合分泌评分每升高1个标准差,急性肾小管坏死的比值比为0.34(95%CI 0.15至0.67)。
  • 综合分泌评分诊断急性肾小管坏死的受试者工作特征曲线下面积为0.73(95%CI 0.60至0.85)。

核心结论

  • 肝硬化合并急性肾损伤的住院患者中,急性肾小管坏死患者的肾小管分泌显著低于肾前性氮质血症和肝肾综合征患者。
  • 这些结果支持使用肾小管分泌对肝硬化急性肾损伤进行鉴别诊断,并可能具有重要的治疗和预后意义。

研究设计与样本

  • 从北美四家三级医疗中心收集76例肝硬化合并急性肾损伤住院患者的配对血浆和点尿标本。
  • 用串联质谱法检测血液和尿液中已知被分泌的一组内源性代谢物。
  • 通过平均内源性分泌标志物的标准化点尿与血浆比值得出综合分泌评分,尿浆比值越高反映肾小管分泌越强。
  • 评估综合分泌评分区分急性肾小管坏死与非急性肾小管坏死的能力。

主要发现

  • 76例肝硬化合并急性肾损伤患者中,39例(51%)为肾前性氮质血症,13例(17%)为肝肾综合征,24例(32%)为急性肾小管坏死。
  • 综合分泌评分中位数在急性肾小管坏死为50.3(95%CI 42.2至61.2),显著低于肾前性氮质血症的61.7(95%CI 55.4至75.4)或肝肾综合征的62.5(95%CI 55.6至66.5)(P=0.007)。
  • 在调整临床特征、基线eGFR和终末期肝病模型评分的模型中,综合分泌评分越高与急性肾小管坏死风险越低相关(综合分泌评分每升高1个标准差的比值比0.34;95%CI 0.15至0.67)。
  • 综合分泌评分诊断急性肾小管坏死与其他原因所致急性肾损伤的受试者工作特征曲线下面积为0.73(95%CI 0.60至0.85)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

KEY POINTS: In cirrhotic patients with AKI, tubular secretion differentiates those with acute tubular necrosis versus other causes. Different secretory function by cause of AKI may affect treatment approaches and drug dosing in patients with cirrhosis and AKI. BACKGROUND: AKI is a common and severe complication among hospitalized patients with cirrhosis. The most common causes of AKI in cirrhosis are prerenal azotemia (PRA), hepatorenal syndrome (HRS), and acute tubular necrosis (ATN), and treatment depends on its causes. Kidney proximal tubular secretion is an essential mechanism for elimination of many drugs and toxins and may be affected in AKI. We hypothesized that assessing secretion would help distinguish between structural tubular injury (ATN) and hemodynamic perturbations (PRA and HRS). METHODS: We collected paired plasma and spot urine specimens from 76 hospitalized patients with cirrhosis and AKI from four tertiary care centers in North America. A panel of endogenous metabolites known to be secreted was measured in blood and urine by tandem mass spectrometry, and a summary secretion score was calculated by averaging the standardized spot urine-to-plasma ratios of the endogenous secretion markers, with higher urine-to-plasma ratios reflecting greater tubular secretion. The summary secretion score was assessed for its ability to discriminate ATN from non-ATN. RESULTS: Among the 76 patients with cirrhosis and AKI, 39 (51%) had PRA, 13 (17%) had HRS, and 24 (32%) had ATN. Median secretion scores were significantly lower in ATN (50.3; 95% confidence intervals [CIs], 42.2 to 61.2) compared with PRA (61.7; 95% CI, 55.4 to 75.4) or HRS (62.5; 95% CI, 55.6 to 66.5; P = 0.007). In models adjusted for clinical characteristics, baseline eGFR, and model for end stage liver disease score, higher summary secretion score was associated with lower odds of ATN (odds ratio per SD higher secretion score, 0.34; 95% CI, 0.15 to 0.67). The summary secretion score showed good discriminative ability in diagnosing ATN versus other causes of AKI (area under the receiver operating curve, 0.73; 95% CI, 0.60 to 0.85). CONCLUSIONS: In patients with cirrhosis and AKI, substantially lower tubular secretion was observed among inpatients with ATN relative to those with PRA and HRS. These results support the use of tubular secretion for the differential diagnosis of AKI in cirrhosis and may have important therapeutic and prognostic implications.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Puthumana J, Belcher JM, Garcia-Tsao G, et al. Kidney Tubule Secretion Can Discriminate the Cause of Acute Kidney Injury in Cirrhosis. Clin J Am Soc Nephrol. 2025. PMID: 40956621. doi:10.2215/CJN.0000000814

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。